The present invention provides a process for preparing a water splitting catalyst containing [Mn.sub.4CaO.sub.4] core structure and use thereof. The present invention provides clusters containing [Mn.sub.4CaO.sub.4] core structure by a chemical synthesis using inexpensive metal ions (Mn.sup.2+, Ca.sup.2+ ions), simple carboxyl ligands and a permanganate, performed single crystal X-ray diffraction on their space structure, and characterized their physical and chemical properties with electron spectrum, electrochemical and electron paramagnetic resonance technologies and the like. These compounds can catalyze water splitting in the presence of oxidant to release oxygen and can also catalyze water splitting on the surface of an electrode to release electrons onto the surface of the electrode to form a current.

Compositions and methods for visualizing tissue under illumination with near-infrared radiation, including compounds comprising near-infrared, closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands are disclosed.

A multi-component detergent, including at least two components, that is contained in a container having at least two chambers, wherein a first component K1 is a first liquid composition, containing at least one catechol metal complex compound of formula (I) ##STR00001##
and at least one free catechol compound of formula (II) or the salt thereof ##STR00002##
with the proviso that the catechol compound of formula (II) and the salt thereof are different from the compounds of formula (I), and a second component K2 is a second liquid composition, containing at least one surfactant. The present invention further relates to the use of the multi-component detergent for removing bleachable stains and a method for washing textiles using the multi-component detergent.

The present invention relates to methods of manufacturing multiple metal propionates in a single reaction using sodium hydroxide as initiator and propionic acid as solvent. The method provides up to 95% conversion with greater than 60% yield. In addition, the method significantly reduces the cost or production by shortening reaction time, eliminating secondary mixing process, and providing simultaneous drying and micronization steps.

A compound for measurement of thiopurine pathway directed systems imaging and therapy including a chelator and a thiopurine ligand is provided. A method of synthesizing the compound is also provided, and the compound may be further prepared in pharmaceutical formulations or kits for therapy or molecular imaging.

Catechol metal complex compounds of formula (I) ##STR00001##
are colored and can be used to give color to surfactant compositions. Detergents containing these catechol metal complex compounds do not stain the textile even after repeated use.

The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the solid organic acid is subjected to intensive mechanical stress. According to the invention, this is done in that the reaction partners are introduced in particle form into a fluid stream of a fluid-bed countercurrent mill operating without grinding elements, wherein mechanical activation of at least one of the reaction partners is effected by collision processes within a reaction chamber formed in a region of the fluid stream, and a solid body reaction to form the metal chelate is triggered. The novel method operates very energy-efficiently and with a high specific yield. It leads to a product having compact particles in the small, single-digit micrometer range having a comparatively narrow particle size distribution and a large surface. The product is homogenous and very pure. Thermal loading or decomposition of the organic chelate ligands, in particular of the amino acids, is likewise avoided, as are contaminants from milling and grinding element abrasion.

Complex containing betaine, transition metal and sulfate in a ratio of 1:1:1, the transition metal being coordinated with two oxygen atoms from the betaine.

The invention relates to a novel radiopharmaceutical that inhibits the prostate-specific membrane antigen (iPSMA), containing hydrazinonicotinamide (HYNIC) as a critical chemical group in increasing in the lipophilicity of the molecule for binding to the hydrophobic sites of the PSMA, combined with the conventional use of HYNIC as a chelating agent for radiometal .sup.99mTc, in which the ethylenediaminetetraacetic acid (EDDA) is used to complete the coordination sphere of the radiometal. The novel radiopharmaceutical .sup.99mTc-EDDA/HYNIC-iPSMA detects, with high affinity and sensitivity in vivo, the overexpressed PSMA protein in prostate cancer cells using SPECT molecular imaging techniques in nuclear medicine. The aim of the invention is to provide a novel specific radiopharmaceutical (radiopharmaceutical for molecular targets) for SPECT, with high sensitivity for the detection of tumours with overexpression of PSMA.

Aspects of the present disclosure relate to compounds which have enhanced oral bioavailability. A transition metal complex includes a transition metal coordinated by a macrocycle comprising the pentaaza 15-membered macrocyclic ring corresponding to Formula A and two axial ligands having the formula OC(O)X.sub.1.

##STR00001## each of the two axial ligands has the formula OC(O)X.sub.1 wherein each X.sub.1 is independently substituted or unsubstituted phenyl or C(X.sub.2)(X.sub.3)(X.sub.4); each X.sub.2 is independently substituted or unsubstituted phenyl, or substituted or unsubstituted alkyl; each X.sub.3 is independently hydrogen, hydroxyl, alkyl, amino, X.sub.5C(O)R.sub.13 where X.sub.5 is NH or O, and R.sub.13 is C.sub.1-C.sub.18 alkyl, substituted or unsubstituted aryl or C.sub.1-C.sub.18 aralkyl, or OR.sub.14, where R.sub.14 is C.sub.1-C.sub.18 alkyl, substituted or unsubstituted aryl or C.sub.1-C.sub.18 aralkyl, or together with X.sub.4 is (O); and each X.sub.4 is independenly hydrogen or together with X.sub.3 is (O).